Resources
About Us
Meticulous Research®—a leading global market research company, published a research report titled 'Ocular Implants Market Size, Share, Forecast, & Trends Analysis by Type (Scleral, Stock, Orbital, Intraocular, Retinal, Corneal) Material (Silicon, Hydroxyapatite) Application (Prosthesis, Ocuplasty, Glaucoma Surgery) End User - Global Forecast to 2031.'
According to this latest publication from Meticulous Research®, the ocular implant market is projected to reach $23.43 billion by 2031 at a CAGR of 6.1% from 2024 to 2031. The growth of the ocular implants market is driven by the rising geriatric population coupled with the high prevalence of eye diseases, the rise in adoption of minimally invasive surgeries, increasing healthcare expenditure, technological advancements in ocular implants, and increasing accident cases, raising the need for ocular implants. However, the risk of post-surgery infection and inflammation, lack of skilled ophthalmic surgeons, strict regulations, and approval process restrain the growth of this market.
Additionally, the lack of awareness in rural areas, technological complexities, high implant costs, and increasing product recalls are major challenges for the players operating in this market. Furthermore, biomaterial-based ocular implants, AI-driven 3D-printed prosthetic eyes, and drug-eluting implants are trends in the ocular implants market.
Key Players
The key players operating in the ocular implant market are Alcon Inc. (Switzerland), Bausch + Lomb Corporation (Canada), Carl Zeiss AG (Germany), Johnson & Johnson Vision Care, Inc. (U.S), STAAR SURGICAL COMPANY (U.S), Morcher GmbH (Germany), HOYA CORPORATION (Japan), GLAUKOS CORPORATION (U.S), AbbVie Inc. (U.S.), and Vivani Medical Inc. (U.S).
Ocular Implants Market: Future Outlook
The ocular implant market is segmented by Type (Non Functional Implant [Ocular Implant {Scleral Shells, Stock Shells, and Custom-made Prosthesis}, and Orbital Implant], Functional Implant [Intraocular Lens, Glaucoma Implant, Retinal Implant, and Corneal Implant]), by Material (Inert Materials [Glass, Silicone, Methyl Methacrylate], and Biointegrated Materials [Hydroxyapatite, Porous Polyethylene, Aluminum Oxide), by Application (Ocular Prosthesis, Glaucoma Surgery, Oculoplasty, Drug Delivery, and Other Applications), by End User (Hospitals, Ophthalmic Clinics, and Ambulatory Surgery Centers (ASCs), Other End Users), and Geography. The study also evaluates industry competitors and analyzes the market at the global and regional levels.
Among all the types studied in this report, in 2024, the functional implant segment is expected to account for the largest share of the ocular implant market. The segment is further categorized into ocular implant and orbital implant. The large share of this segment is attributed to the rising geriatric population coupled with the high prevalence of eye diseases, the rising adoption of minimally invasive eye surgeries, and increasing accident cases injuring eyes. For instance, according to the Johns Hopkins University report of 2024, eye injuries impact 2.5 million people worldwide annually. Such instances are expected to drive the demand for ocular implants.
Among all the materials studied in this report, in 2024, the inert materials segment is expected to account for the largest share of the ocular implant market. This segment is further categorized into glass, silicone, and methylmethacrylate. The large market share of this segment can be attributed to the cost-effectiveness of inert materials and the high preference for glass and silicone material-based ocular implants due to their high compatibility and excellent visual appearance.
Among all the applications studied in this report, in 2024, glaucoma surgery is expected to account for the largest share of the ocular implant market. Glaucoma develops when optical nerves are damaged due to eye injury, high age, diabetes, and genetics. For instance, according to the World Health Organization (WHO) August 2023 report, approximately 7.7 million people had glaucoma in the world. Furthermore, increasing healthcare expenditure and easy accessibility to ocular implants are supporting the segment’s large share.
Among all the end users studied in this report, in 2024, the hospitals segment is expected to account for the largest share of the ocular implant market. The large share of the segment is attributed to the increasing number of hospitals, the availability of advanced instruments with eye specialists in hospitals, and a large number of patients preferring hospitals as the first option for treatment.
Geographic Review
This research report analyzes major geographies and provides a comprehensive analysis of the market in North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, Netherlands, Sweden, Belgium, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Rest of Latin America), and the Middle East & Africa.
Among all regions studied in this report, in 2024, North America is expected to account for the largest share of the ocular implant market. The large share of this segment is attributed to increasing cases of eye disorders, the presence of key players with well-established distribution channels globally, and the availability of technologically advanced products. For instance, according to the Canadian Association of Optometrists (Canada), in 2023, more than 450,000 people are suffering from glaucoma in Canada . Such instances are expected to drive the ocular implants market.
Asia-Pacific is expected to register the highest CAGR during the forecast period. The growth of this region is attributed to the increasing number of diabetic patients who are likely to suffer from eye diseases such as glaucoma and age-related macular degeneration, rising geriatric population, increasing healthcare expenditure, emerging healthcare landscape, and regional governments' investment in the development of healthcare infrastructure. For instance, according to the World Health Organization (WHO), China has the fastest-growing aging population in the world, and it is estimated that by 2040, 402 million people, approximately 28% of the total population, will be over the age of 60 . The older population is more likely to be affected by eye diseases, which is expected to support the growth of the market in the region.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5928
Key questions answered in the report:
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Bakuchiol Serum Market to Reach $4.41 Million by 2031
Read MoreBurn Care Market to be Worth $4.32 Billion by 2031
Read MoreAfrica Medical Devices Market to be Worth $7.14 Billion by 2031
Read MoreMiddle East Medical Devices Market to be Worth $8.8 Billion by 2031
Read MoreSurgical Drills Market to be Worth $1.71 Billion by 2031
Read MoreTissue Engineering Market to reach $7.41 Billion by 2031
Read MoreDental Prosthetics Market to be Worth $ 19.6 Billion by 2031
Read MoreIVD Assay Development Market to be Worth $8.39 Billion by 2031
Read MoreNeurogenomics Market to Reach $4.68 Billion by 2031
Read MoreIndia VNA & PACS Market to Reach $341.6 Million by 2031
Read MoreChina Microarray Market to Be Worth $910.4 Million by 2031
Read MoreChina Neurogenomics Market to Reach $562.1 Million by 2031
Read MoreELISA Market to be Worth $32.69 Billion by 2031
Read MoreDNA Sequencing Market to be Worth $21.30 Billion by 2031
Read MoreOral Care Market to be Worth $58.99 Billion by 2031
Read MoreSpirometer Market to be Worth $1.80 Billion by 2031
Read MorePet Care Market to be Worth $287.96 Billion by 2031
Read MoreRegenerative Medicine Market to be Worth $37.27 Billion by 2031
Read MoreHemostats Market to be Worth $5.32 Billion by 2031
Read MoreBioreactors Market to be Worth $39.96 Billion by 2031
Read MoreProtein Assays Market to be Worth $4.36 Billion by 2031
Read MoreVeterinary API Market to Reach $15.84 Billion by 2031
Read MoreAsia-Pacific NGS Automation Market to be Worth $371 Million by 2031
Read MoreLatin America NGS Market to be Worth $765.2 Million by 2031
Read MoreBiochemical Reagents Market to be Worth $39.61 Billion by 2031
Read MoreMicroarray Kits Market to be Worth $2.51 Billion by 2031
Read MoreAntibody Production Market to Reach $58.35 Billion by 2031
Read MoreMiddle East IVD Market to be Worth $2.15 Billion by 2031
Read MoreSpatial Genomics Market to be Worth $3.23 Billion by 2031
Read MoreAsia-Pacific IVD Market to be Worth $36.02 Billion by 2031
Read MoreEurope NGS Market to be Worth $6.40 Billion by 2030
Read MoreLab Automation Market to be Worth $11.31 Billion by 2031
Read MoreBioinformatics Market to Reach $31.71 Billion by 2031
Read MoreEurope IVD Market to be Worth $39.77 Billion by 2030
Read MoreSequencing Kits Market to be Worth $25.29 Billion by 2031
Read MoreVeterinary API Market to Reach $15.84 Billion by 2031
Read MoreU.S. Ambulatory EHR Market to be Worth $3.97 Billion by 2031
Read MoreSample Preparation Market to be Worth $12.77 Billion by 2031
Read MoreSurgical Robots Market Worth $25.47 Billion by 2030
Read MoreMedical Coatings Market Worth $3.32 Billion by 2030
Read MoreDigital Therapeutics Market to be Worth $56.34 Billion by 2031
Read MoreLiquid Handling Systems Market Worth $6.99 Billion by 2029
Read MoreElectrosurgery Market to be Worth $8.99 Billion by 2031
Read MoreRadiation Dose Management Market Worth $749.1 Million by 2029
Read MoreMolecular Diagnostics Market Worth $46.69 Billion by 2030
Read MoreNewborn Screening Market to be Worth $2.69 Billion by 2031
Read MorePharmacogenomics Market to be Worth $19.5 Billion by 2031
Read MoreDental Practice Management Software Market Worth $ 3.11 Billion by 2029
Read MoreNepal IVD Market Worth $62.7 Million by 2029
Read MorePharmaceutical Contract Packaging Market Worth $42.03 Billion by 2029
Read MoreIndonesia IVD Market Worth $1.11 Billion by 2029
Read MoreMedical Waste Management Market Worth $17.02 billion by 2030
Read MoreEmpty Capsules Market Worth $4.47 Billion by 2029
Read MoreClear Aligners Market to be worth $18.8 Billion by 2030
Read MoreHLA Typing Market Worth $1.9 Billion by 2029
Read MoreReal-world Data Market Worth $1.66 billion by 2029
Read MoreTrack and Trace Solutions Market Worth $27.27 billion by 2029
Read MoreSurface Disinfectant Market Worth $9.52 Billion by 2029
Read MoreElectronic Lab Notebook Market Worth $787.7 million by 2029
Read MoreRapid Diagnostics Market to be Worth $22.65 Billion By 2031
Read MorePlasma Therapy Market Worth $882.5 Million by 2028
Read MorePeripheral Vascular Devices Market Worth $12.02 Billion by 2028
Read MoreBiomaterials Market to Reach 128.7 Billion USD by 2023
Read MoreVaccine Storage Equipment Market Worth $1.83 billion by 2027
Read MorePlasma Fractionation Market Worth $46.9 Billion by 2029
Read MoreHome Healthcare Market to be Worth $514.5 Billion by 2030
Read MoreCardiac Pacemaker Devices Market Worth $4.34 Billion by 2028
Read MoreEuropean Laboratory Informatics Market Worth $1,084.3 Million By 2024
Read MoreCompetent Cells Market Worth 2,318.6 Million USD By 2023
Read MoreCancer Immunotherapy Market to be Worth $267.2 Billion by 2030
Read MoreMultimodal Imaging Market Worth $1.6 Billion By 2024
Read MorePulse Lavage Market to be Worth $661.1 Million by 2030
Read MoreMedical Cooling Systems Market Worth $2.8 Billion By 2024
Read MoreTissue Diagnostics Market Worth $8.52 Billion by 2029
Read MoreEndoscopy Equipment Market Worth $59.8 Billion by 2029
Read MoreAfrican Forensic DNA Testing Market Worth $136.3 Million by 2025
Read MoreClinical Trial Supplies Market to be Worth $5.59 Billion by 2031
Read MoreInfection Control Market Worth $58.2 Billion by 2027
Read MoreSleep Apnea Devices Market Worth $12.9 billion by 2027
Read MoreMedical 3D Printing Market To Reach $983.2 Million By 2020
Read MoreGenomics Market to be Worth $70.52 Billion by 2031
Read MoreAnalytical Standards Market Worth $2.66 Billion By 2027
Read MoreTelehealth Market Worth $539.73 Billion by 2029
Read MoreCell Culture Market Worth $48.63 Billion by 2029
Read MoreAntimicrobial Coatings Market to be Worth $12.41 Billion by 2031
Read MoreFlow Cytometry Market Worth $6.4 Billion by 2027
Read MoreMedical Aesthetics Market Worth $29.43 billion by 2029
Read MoreOligonucleotide Synthesis Market Worth $3.9 Billion by 2025
Read MoreIn Vitro Diagnostics Market to be Worth $116.28 Billion by 2031
Read MoreDental Implants Market Worth $6.52 Billion by 2029
Read MoreActive Implantable Devices Market Worth 24.02 Billion USD By 2022
Read MoreVentilators Market to be Worth $13.23 Billion by 2031
Read MoreDialysis Market to be Worth $36.6 Billion by 2031
Read MorePlasmapheresis Market to be Worth $2.55 Billion by 2030
Read MoreDiabetes Care Devices Market Worth $31.9 Billion by 2028
Read MoreClinical Genomics Market Worth 879.0 Million USD By 2023
Read MoreIVD Quality Control Market to be Worth $2.28 Billion by 2031
Read MoreLaboratory Informatics Market Worth $6.1 Billion by 2030
Read MoreChromatography Data Systems Market to be Worth $1.7 billion by 2030
Read MoreBone Growth Stimulators Market Worth $1.94 Billion by 2030
Read MoreDigital Diabetes Market worth $12.03 billion by 2025
Read MoreTrocars Market Worth $968.5 Million by 2024
Read MoreHealthcare Virtual Assistant Market Worth $1.76 Billion By 2025
Read MoreEurope Hospital Beds Market to be Worth $2.09 Billion by 2030
Read MoreImmunoassay Market Worth $46.49 Billion by 2028
Read MoreHospital Beds Market to Reach $7.09 Billion by 2031
Read MoreUrinalysis Market Worth $2.19 billion by 2027
Read MoreMedical Image Management Market Worth $7.22 billion by 2030
Read MoreBreast Imaging Market Worth $7.08 Billion by 2027
Read MoreVNA & PACS Market to be Worth $6.50 Billion by 2031
Read More